Edition:
United States

Agilent Technologies Inc (A.N)

A.N on New York Stock Exchange

68.69USD
22 Nov 2017
Change (% chg)

$-1.22 (-1.75%)
Prev Close
$69.91
Open
$69.05
Day's High
$69.36
Day's Low
$68.33
Volume
1,179,794
Avg. Vol
469,978
52-wk High
$70.73
52-wk Low
$42.92

Latest Key Developments (Source: Significant Developments)

Agilent Technologies Q4 non-gaap earnings per share $0.67
Monday, 20 Nov 2017 04:05pm EST 

Nov 20 (Reuters) - Agilent Technologies Inc ::Agilent Technologies reports fourth-quarter fiscal year 2017 financial results.Sees FY 2018 non-gaap earnings per share $2.50 to $2.56.Sees Q1 2018 non-gaap earnings per share $0.55 to $0.57.Q4 gaap earnings per share $0.54.Sees FY 2018 revenue $4.72 billion to $4.74 billion.Sees Q1 2018 revenue $1.145 billion to $1.165 billion.Q4 revenue $1.19 billion versus I/B/E/S view $1.17 billion.Q4 earnings per share view $0.62 -- Thomson Reuters I/B/E/S.Q4 non-gaap earnings per share $0.67.Q4 earnings per share view $0.62, revenue view $1.17 billion -- Thomson Reuters I/B/E/S.FY 2018 earnings per share view $2.59, revenue view $4.73 billion -- Thomson Reuters I/B/E/S.FY 2018 earnings per share view $2.59, revenue view $4.73 billion -- Thomson Reuters I/B/E/S.  Full Article

Agilent technologies increases cash dividend to 14.9 cents per share
Wednesday, 15 Nov 2017 04:05pm EST 

Nov 15 (Reuters) - Agilent Technologies Inc :Agilent technologies increases cash dividend to 14.9 cents per share.  Full Article

Agilent Technologies receives expanded FDA approval for Dako PD-L1 IHC 22C3 pharmDx
Friday, 22 Sep 2017 04:27pm EDT 

Sept 22 (Reuters) - Agilent Technologies Inc :Agilent Technologies receives expanded FDA approval for the use of Dako PD-L1 IHC 22C3 pharmDx companion diagnostic in gastric or gastroesophageal junction (GEJ) cancer.  Full Article

Agilent announces expanded use of cancer diagnostic in U.S.
Tuesday, 19 Sep 2017 09:00am EDT 

Sept 19 (Reuters) - Agilent Technologies Inc ::Says ‍FDA approved cancer diagnostic for use in cases of UC and of Squamous Cell Carcinoma of head & neck​.  Full Article

AGILENT OBTAINS U.S. FDA APPROVAL FOR GENETISURE DX POSTNATAL ASSAY
Wednesday, 13 Sep 2017 11:00am EDT 

Sept 13 (Reuters) - Agilent Technologies Inc ::AGILENT OBTAINS U.S. FDA APPROVAL FOR GENETISURE DX POSTNATAL ASSAY.AGILENT TECHNOLOGIES INC - ‍ASSAY IS INTENDED FOR USE ON AGILENT SURESCAN DX MICROARRAY SCANNER SYSTEM​.  Full Article

Agilent Technologies reports Q3 non-GAAP earnings per share of $0.59
Tuesday, 15 Aug 2017 04:05pm EDT 

Aug 15 (Reuters) - Agilent Technologies Inc :Agilent Technologies reports third-quarter fiscal year 2017 financial results.Sees Q4 2017 non-GAAP earnings per share $0.60 to $0.62.Sees FY 2017 non-GAAP earnings per share $2.29 to $2.31.Q3 GAAP earnings per share $0.54.Sees Q4 2017 revenue $1.15 billion to $1.17 billion.Sees FY 2017 revenue $4.435 billion to $4.455 billion.Q3 earnings per share view $0.52 -- Thomson Reuters I/B/E/S.Q3 non-GAAP earnings per share $0.59.Agilent Technologies Inc - ‍raising fiscal year 2017 free cash flow guidance by $40 million to $665 million​.Agilent Technologies Inc - qtrly ‍revenue of $1.11 billion, representing growth of 7 percent​.FY 2017 earnings per share view $2.23, revenue view $4.40 billion -- Thomson Reuters I/B/E/S.Q3 revenue view $1.09 billion -- Thomson Reuters I/B/E/S.  Full Article

Agilent acquires Next Generation Sequencing IP portfolio
Monday, 24 Jul 2017 04:30pm EDT 

July 24 (Reuters) - Agilent Technologies Inc :Agilent acquires powerful Next Generation Sequencing IP portfolio.Agilent Technologies Inc - ‍financial terms of purchase were not disclosed​.Agilent Technologies Inc - ‍acquired Population Genetics IP includes patents related to both molecular and sample barcoding​.  Full Article

Agilent Technologies says on July 14 entered into amendment no.1 to credit agreement with lenders and agent - SEC filing
Monday, 17 Jul 2017 04:28pm EDT 

July 17 (Reuters) - Agilent Technologies Inc :Agilent Technologies Inc - on July 14, 2017, company, lenders and agent entered into amendment number 1 to credit agreement - SEC filing.Agilent Technologies Inc - amendment further increased commitments under facility by an additional $300 million - SEC filing.Agilent Technologies Inc - aggregate commitments under facility now total $1.0 billion.  Full Article

Agilent Technologies acquires Raman Spectroscopy Innovator
Friday, 7 Jul 2017 08:30am EDT 

July 7 (Reuters) - Agilent Technologies Inc :Agilent Technologies acquires Raman Spectroscopy innovator, Cobalt Light Systems.Agilent Technologies Inc - Agilent is acquiring Cobalt for £40 million in cash.Says Cobalt's CEO will remain with Agilent as director of Raman Spectroscopy.  Full Article

Agilent Technologies, Agendia to develop RNA-SEQ kit version of Agendia's mammaprint, blueprint tests
Friday, 2 Jun 2017 11:00am EDT 

June 2 (Reuters) - Agilent Technologies Inc ::Co, Agendia Inc to expand relationship to develop RNA-SEQ kit version of Agendia's currently marketed mammaprint, blueprint tests.Agreement accelerates development of tests to assess risk of disease recurrence in women with early-stage breast cancer.Initial phase of RNA-SEQ kit development is expected to be completed in 2017, providing early access to limited markets in Europe.  Full Article

BRIEF-Agilent Technologies Q4 non-gaap earnings per share $0.67

* Agilent Technologies reports fourth-quarter fiscal year 2017 financial results